Works matching IS 15747891 AND DT 2025 AND VI 19 AND IP 2

Results: 20
    1

    Issue Information.

    Published in:
    Molecular Oncology, 2025, v. 19, n. 2, p. 265, doi. 10.1002/1878-0261.13822
    Publication type:
    Article
    2

    Reviewers Acknowledgement.

    Published in:
    Molecular Oncology, 2025, v. 19, n. 2, p. 572, doi. 10.1002/1878-0261.13809
    Publication type:
    Article
    3

    Oncogenic mutant KRAS inhibition through oxidation at cysteine 118.

    Published in:
    Molecular Oncology, 2025, v. 19, n. 2, p. 311, doi. 10.1002/1878-0261.13798
    By:
    • Kramer‐Drauberg, Maximilian;
    • Petrini, Ettore;
    • Mira, Alessia;
    • Patrucco, Enrico;
    • Scardaci, Rossella;
    • Savinelli, Ilenia;
    • Wang, Haiyun;
    • Qiao, Keying;
    • Carrà, Giovanna;
    • Nokin, Marie‐Julie;
    • Zhou, Zhiwei;
    • Westover, Kenneth D.;
    • Santamaria, David;
    • Porporato, Paolo E.;
    • Ambrogio, Chiara
    Publication type:
    Article
    4

    Evaluation of circulating tumor DNA as a prognostic and predictive biomarker in BRAFV600E mutated colorectal cancer—results from the FIRE‐4.5 study.

    Published in:
    Molecular Oncology, 2025, v. 19, n. 2, p. 344, doi. 10.1002/1878-0261.13778
    By:
    • Klein‐Scory, Susanne;
    • Baraniskin, Alexander;
    • Schmiegel, Wolff;
    • Mika, Thomas;
    • Schroers, Roland;
    • Held, Swantje;
    • Heinrich, Kathrin;
    • Tougeron, David;
    • Modest, Dominik P.;
    • Schwaner, Ingo;
    • Eucker, Jan;
    • Pihusch, Rudolf;
    • Stauch, Martina;
    • Kaiser, Florian;
    • Kahl, Christoph;
    • Karthaus, Meinolf;
    • Müller, Christian;
    • Burkart, Christof;
    • Stintzing, Sebastian;
    • Heinemann, Volker
    Publication type:
    Article
    5
    6
    7
    8
    9

    Minimally invasive determination of pancreatic ductal adenocarcinoma (PDAC) subtype by means of circulating cell‐free RNA.

    Published in:
    Molecular Oncology, 2025, v. 19, n. 2, p. 357, doi. 10.1002/1878-0261.13747
    By:
    • Metzenmacher, Martin;
    • Zaun, Gregor;
    • Trajkovic‐Arsic, Marija;
    • Cheung, Phyllis;
    • Reissig, Timm M.;
    • Schürmann, Hendrik;
    • von Neuhoff, Nils;
    • O'Kane, Grainne;
    • Ramotar, Stephanie;
    • Dodd, Anna;
    • Gallinger, Steven;
    • Muckenhuber, Alexander;
    • Knox, Jennifer J.;
    • Kunzmann, Volker;
    • Horn, Peter A.;
    • Hoheisel, Jörg D.;
    • Siveke, Jens T.;
    • Lueong, Smiths S.
    Publication type:
    Article
    10
    11
    12
    13
    14
    15

    KRAS<sup>G</sup><sup>12C</sup>‐inhibitor‐based combination therapies for pancreatic cancer: insights from drug screening.

    Published in:
    Molecular Oncology, 2025, v. 19, n. 2, p. 295, doi. 10.1002/1878-0261.13725
    By:
    • Tapia Contreras, Constanza;
    • Falke, Jonas Dominik;
    • Seifert, Dana‐Magdalena;
    • Schneider, Carolin;
    • Krauß, Lukas;
    • Fang, Xin;
    • Müller, Denise;
    • Demirdizen, Engin;
    • Spitzner, Melanie;
    • De Oliveira, Tiago;
    • Schneeweis, Christian;
    • Gaedcke, Jochen;
    • Kaulfuß, Silke;
    • Mirzakhani, Kimia;
    • Wollnik, Bernd;
    • Conrads, Karly;
    • Beißbarth, Tim;
    • Salinas, Gabriela;
    • Hügel, Jonas;
    • Beyer, Nils
    Publication type:
    Article
    16
    17

    Loss of Lkb1 cooperates with Braf<sup>V600E</sup> and ultraviolet radiation, increasing melanoma multiplicity and neural‐like dedifferentiation.

    Published in:
    Molecular Oncology, 2025, v. 19, n. 2, p. 329, doi. 10.1002/1878-0261.13715
    By:
    • McGrail, Kimberley;
    • González‐Sánchez, Elena;
    • Granado‐Martínez, Paula;
    • Orsenigo, Roberto;
    • Ding, Yuxin;
    • Ferrer, Berta;
    • Hernández‐Losa, Javier;
    • Ortega, Iván;
    • Martín‐Caballero, Juan;
    • Muñoz‐Couselo, Eva;
    • García‐Patos, Vicente;
    • Recio, Juan A.
    Publication type:
    Article
    18
    19
    20